Factory making Cas No.34532-68-8 - Cimifugin CAS No. 37921-38-3 – Yongjian
Factory making Cas No.34532-68-8 - Cimifugin CAS No. 37921-38-3 – Yongjian Detail:
Essential Information
[English Name] Cimifugin
[English Alias] (2S)-7-(Hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro[3,2-g]chromen-5-one; (2S)-7-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydro-5H-furo[3,2-g]chromen-5-one; 7-(hydroxymethyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydro-5H-furo[3,2-g]chromen-5-one [1]
[molecular formula] C16H18O6
[molecular weight] 306.31052
[CAS No.] 37921-38-3
[chemical classification] chromones chromogen ketones
[source] cimicfuga goetida L
[Specification] > 98%
[character] white powder
Customized Service of Chemical Reference Materials of Traditional Chinese Medicine
Jiangsu Yongjian Pharmaceutical Technology Co., Ltd. is mainly engaged in the basic research of active substances of traditional Chinese medicine for more than ten years. So far, the company has conducted in-depth research on more than 100 kinds of commonly used traditional Chinese medicine, and extracted thousands of chemical components.
The company has top R & D personnel and perfect testing and analysis equipment in the industry, and has served hundreds of scientific research institutions. It can quickly and efficiently meet customer needs.
Drug Impurity Separation, Preparation and Structure Confirmation Service
Impurities in drugs are closely related to the quality, safety and stability of drugs. The preparation and structure confirmation of impurities in drugs can help us understand the ways of impurities and provide a basis for the improvement of production process. Therefore, the preparation and separation of impurities is of great significance to drug research and development.
However, the content of impurities in the drug is low, the source is wide, and the structure is mostly similar to the principal component. What technology can be used to quickly separate and purify all impurities in the drug one by one? What techniques and methods are used to confirm the structure of these impurities? This is the difficulty and challenge faced by many pharmaceutical units, especially the pharmaceutical enterprises of plant medicine and Chinese patent medicine.
Based on such needs, the company has launched drug impurity separation and purification services. Relying on nuclear magnetic resonance, mass spectrometry and other equipment and technologies, the company can quickly identify the structure of the separated compounds, so as to meet the needs of customers.
SPF Animal Experiment
The construction area of the animal experimental area is 1500 square meters, including 400 square meters of SPF level experimental area and 100 square meters of P2 level cell laboratory. Led by scientists of China Pharmaceutical University, it forms a core technical team with a number of returnees. Provide high-quality animal models, experimental design, overall projects and other services for biomedical scientific research, teaching and industrial development.
Product detail pictures:
Related Product Guide:
Having a sound small business credit score, outstanding after-sales services and modern manufacturing facilities, we've got earned an fantastic reputation among our buyers across the globe for Factory making Cas No.34532-68-8 - Cimifugin CAS No. 37921-38-3 – Yongjian , The product will supply to all over the world, such as: United States, Thailand, Irish, Our company has already have pass the ISO standard and we are fully respect our customer 's patents and copyrights. If the customer provides their own designs, We will guarantee that they will be the only one can have that products. We hoping that with our good products can bring our customers a great fortune.
By Elizabeth from Argentina - 2018.02.04 14:13
The sales manager has a good English level and skilled professional knowledge, we have a good communication. He is a warm and cheerful man, we have a pleasant cooperation and we became very good friends in private.
By Rebecca from kazan - 2017.09.26 12:12